Brief: Alterity Therapeutics Says Ath434-201 Study To Complete In November 2024
22/01/2024 12:39
Jan 22 (Reuters) - Alterity Therapeutics Ltd ATH.AX :
* ALTERITY THERAPEUTICS LTD - ATH434-201 STUDY TO COMPLETE
IN
NOVEMBER 2024
* ALTERITY THERAPEUTICS LTD - PRELIMINARY DATA FROM
ATH434-202
STUDY EXPECTED IN 1H 2024
* ALTERITY THERAPEUTICS LTD - ATH434-201 STUDY TO COMPLETE
IN
NOVEMBER 2024
* ALTERITY THERAPEUTICS LTD - EXPECT TO MAKE ADDITIONAL
PROGRESS
WITH BIOMUSE AND ADVANCEMENT OF ATH434 IN PARKINSON'S DISEASE
Source text for Eikon: ID:nGNX9ZmKDZ
Further company coverage: ATH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital